RxDoctor Payments Data

Harvey Smith, MD

Orthopaedic Surgery · Philadelphia, PANPI 1699979484

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $9,700 of the $14,464 with a category attached, or 67.1%. Kuros Biosciences USA, Inc accounts for 81.7% of it on its own, with 14 other manufacturers making up the rest. 2025 is the largest year on record at $11,602, more than ten times the $527 reported in 2019.

$14,464in general payments, 2019–2025

Across 60 payments — averaging $241.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Kuros Biosciences USA, Inc$12K
  • Johnson & Johnson$777
  • Stryker$504
  • Orthofix Medical, Inc.$504
  • Si-bone, Inc.$168
  • Globus Medical$136
  • plus $560 from 9 others
$26,638in research payments, 2019–2025

Across 6 payments — averaging $4439.67 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medical Device Business Services, Inc.$27K

What the payments were for

  • Consulting fees$9,70067%
  • Travel & lodging$4663%
  • Food & beverage$4,29830%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$14,464 in reported general payments places this provider in the 75th percentile of 1,048 orthopaedic surgery providers in Pennsylvania.

See all orthopaedic surgery providers in Pennsylvania →

Medicare billing

Part B allowed, 2024
$138,215
Medicare patients
222
Services billed
476

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin12$145

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Philadelphia

See the full list for Pennsylvania →

Where these figures come from

Is this you, or does something look wrong? →